301501.SHE Hefei Hengxin Life Science and Technology Co., Ltd.
- Market cap
- CNY 3.49B
- P/E
- 26.2x
- P/B
- 1.61x
- ROE
- 5.9%
- Dividend yield
- 1.69%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.
Is 301501.SHE undervalued?
Graham number301501.SHE trades 36.8% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Hefei Hengxin Life Science and Technology Co., Ltd. fundamental analysis
No fundamental analysis for Hefei Hengxin Life Science and Technology Co., Ltd. yet.
Hefei Hengxin Life Science and Technology Co., Ltd. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Hefei Hengxin Life Science and Technology Co., Ltd.
Hefei Hengxin Life Science and Technology Co., Ltd. engages in the research and development, production, and sale of green and low-carbon bio-based products in China, North America, Europe, Asia, Oceania, and internationally. The company researches, develops, produces, and sells bio-based tableware and packaging products, such as PLA/PHA coated paper and PE/PET/PP/PS, including cups/bowls, lunch boxes, cups/lids, cutlery, straws, paper cup sleeves/carriers, paper bags, and o…
Full company profileHefei Hengxin Life Science and Technology Co., Ltd. financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Hefei Hengxin Life Science and Technology Co., Ltd. annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|
| Income Statement | ||||||
| Revenue | 719M | 1.09B | 1.43B | 1.59B | 1.84B | 1.87B |
| Gross Profit | 719M | 306M | 408M | 419M | 443M | 346M |
| Operating Income | 719M | 196M | 270M | 266M | 255M | 160M |
| EBITDA | - | 239M | 319M | 357M | 406M | 151M |
| Net Income | 80.3M | 163M | 214M | 220M | 224M | 124M |
| EPS | 0.72 | 1.47 | 1.93 | 1.98 | 1.51 | 0.84 |
| Balance Sheet | ||||||
| Total Assets | 728M | 1.21B | 1.57B | 1.98B | 2.85B | 2.81B |
| Total Liabilities | 246M | 566M | 690M | 869M | 678M | 642M |
| Shareholders' Equity | 0.00 | 609M | 822M | 1.05B | 2.11B | 2.09B |
| Cash & Short-term Investments | 132M | 266M | 225M | 296M | 321M | 369M |
| Cash Flow | ||||||
| Operating Cash Flow | 144M | 293M | 219M | 374M | 340M | - |
| Capital Expenditure | 134M | 290M | 330M | 453M | 528M | 493M |
| Free Cash Flow | 144M | 2.58M | -111M | -78.7M | -188M | -358M |
| Ratios | ||||||
| ROE | - | 26.7% | 26.0% | 21.0% | 10.6% | 5.9% |
| ROA | 11.0% | 13.4% | 13.6% | 11.1% | 7.8% | 4.4% |
| Net Profit Margin | 11.2% | 15.0% | 15.0% | 13.8% | 12.1% | 6.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Hefei Hengxin Life Science and Technology Co., Ltd. dividends
- Dividend yield
- 1.69%
- Forward dividend
- 0.35 CNY
- Payout ratio
- 26.3%
- Ex-dividend date
- Jun 5, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 58.8M | 0.40 | 26.3% |
| 2024 | CNY 11.4M | 0.10 | 5.2% |
| 2023 | CNY 7.63M | 0.07 | 3.6% |
| 2022 | CNY 19.5M | 0.18 | 12.0% |
| 2021 | CNY 9.74M | 0.09 | 12.1% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.45:1 on Jun 6, 2025.
Who owns Hefei Hengxin Life Science and Technology Co., Ltd.
- Insiders 74.20%
- Institutions 1.53%
- Public & others 24.27%
- Shares outstanding 148M
- Free float 41.1M
Hefei Hengxin Life Science and Technology Co., Ltd. company profile
- Company name
- Hefei Hengxin Life Science and Technology Co., Ltd.
- Ticker
- 301501.SHE
- ISIN
- CNE100006VB6
- Exchange
- Shenzhen Stock Exchange
- Sector
- Consumer Cyclical
- Industry
- Packaging & Containers
- Employees
- 2,586
- Fiscal year end
- December
- Address
- No.36 ShuangFeng Road, Hefei, China, 231131
- Phone
- 86 551 6565 7151
- Website
- hfhxin.com
About Hefei Hengxin Life Science and Technology Co., Ltd.
Hefei Hengxin Life Science and Technology Co., Ltd. engages in the research and development, production, and sale of green and low-carbon bio-based products in China, North America, Europe, Asia, Oceania, and internationally. The company researches, develops, produces, and sells bio-based tableware and packaging products, such as PLA/PHA coated paper and PE/PET/PP/PS, including cups/bowls, lunch boxes, cups/lids, cutlery, straws, paper cup sleeves/carriers, paper bags, and other products. It also offers bamboo tableware products, including knives, forks, spoons, chopsticks, straws, and bamboo skewers. Hefei Hengxin Life Science and Technology Co., Ltd. was incorporated in 1997 and is headquartered in Hefei, China.
Hefei Hengxin Life Science and Technology Co., Ltd. management
10- Mr. De Ping YanChairman & GM · born 1963
- Mr. Bo ChenFinancial Director & Director · born 1986
- Mr. Jian XuTechnical Director · born 1979
- Ms. Feng ChenAdministrative & HR Director · born 1983
- Mr. Xiao Hong SunSecretary of the Board of Directors, Director of the GM's Office & Director · born 1982
- Ms. Si Hua ZhangDeputy General Manager · born 1980
- Ms. Chun Xia WangDeputy General Manager · born 1986
- Ms. Yin HuangDeputy General Manager · born 1983
- Mr. Hui LiPaper Product Forming Technology Engineer · born 1978
- Ms. Na TaoEmployee Representative Supervisor & Logistics Supervisor · born 1987